Medicines are the cornerstone of modern healthcare, and advances in managing diseases are founded on the discovery, application and improvement of medicines.
The development of better medicines is a multidisciplinary endeavour which requires expertise in areas ranging from identification of new targets to drug design and testing.
This requires an effective drug discovery cascade including medicinal chemistry, pharmaceutical sciences and biological validation in appropriate disease models.
The translation of new drugs also relies on developing appropriately formulated drug like molecules and drug delivery systems.
The development of better medicines with fewer side effects that are cost effective and appropriately utilised is vital. However, this process is not just about the drug discovery process but also repurposing of existing drugs and therapy, combining treatments for patients specific benefit and prescribing and utilising drugs so that they are optimally effective.
These elements are part of the USP of the University of Strathclyde’s activities in the field of development of better medicines.
Strathclyde Institute of Pharmacy & Biomedical Sciences
The Strathclyde Institute of Pharmacy & Biomedical Sciences (SIPBS) is a major research centre in Scotland and is amongst the UK's top Schools of Pharmacy and pharmacology.
Research into better medicines in SIPBS is supported by departments across the University.
We have a wide range of state-of-the-art facilities housed in a new £36m building and have world class facilities for physical chemistry (CMAC) located in the Technology & Innovation Centre.
Our medicines research engages academics, industry and the health sector.